IPPRA / Grant Monitor

2026-09-06
3129Open opportunities
23IPPRA ≥ 60
0Not yet characterized
580Awaiting detail
2026-09-05Last fetch
Lens
Source
Deadline
Score
Funds
Topic
Category
IPPRA fit Opportunity Topics Ceiling Posted Closes Days
35 Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) PAR-25-226 · National Institutes of Health · other biomedical clinical public health mental behavioral health 2024-11-22 2026-11-19 74
20 Brain Repair of Any Injured Neural Structure (BRAINS) - Proposers' Day ARPA-H-SN-26-153 · NATIONAL INSTITUTES OF HEALTH · ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) · other biomedical clinical public health computing communications 2026-06-08 2027-02-06 153

2 OF 2 ROWS